Thermo Fisher Scientific | TMO - Trade Debtors


Thermo Fisher Scientific reported $9.2B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Abbott USD 10.57B 171M Dec/2025
Agilent USD 1.5B 23M Mar/2026
Becton, Dickinson and Co. USD 2.2B 303M Mar/2026
Bio Techne USD 214.56M 29.95M Mar/2026
Bio-Rad Laboratories USD 460.6M 4.1M Dec/2025
Boston Scientific USD 2.93B 98M Dec/2025
Bruker USD 542.7M 2.2M Mar/2026
Charles River Laboratories USD 700.25M 727.92M Mar/2026
Danaher USD 4.76B 845M Mar/2026
Dentsply International USD 622M 66M Mar/2026
Edwards Lifesciences USD 912.1M 19.3M Dec/2025
General Electric Aerospace USD 22.18B 6.89B Mar/2026
Henry Schein USD 1.72B 68M Mar/2026
Illumina USD 738M 116M Mar/2026
Intuitive Surgical USD 1.6B 68.3M Mar/2026
IQVIA Holdings USD 3.38B 52M Mar/2026
Laboratory Of America USD 2.45B 189.8M Mar/2026
Medtronic USD 6.36B 30M Dec/2025
Mettler Toledo International USD 708.21M 70.04M Mar/2026
Myriad Genetics USD 115.3M 2.7M Dec/2025
Olympus JPY 334.31B 55.98B Mar/2026
OraSure Technologies USD 22.2M 2.1M Dec/2025
Quest Diagnostics USD 1.59B 179M Mar/2026
Repligen USD 151.55M 7.03M Mar/2026
Revvity USD 691.38M 53.29M Mar/2026
Stryker USD 3.57B 468M Mar/2026
Thermo Fisher Scientific USD 9.2B 304M Mar/2026
Veracyte USD 50.11M 5.45M Mar/2026
Waters USD 1.76B 930.16M Mar/2026
Zimmer Biomet Holdings USD 1.73B 24.2M Mar/2026